Eric Siemers
Acumen Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research, Health Systems, Economic Evaluations, Quality of Life, Cholinesterase and Neurodegenerative Diseases, Computational Drug Discovery Methods
Most-Cited Works
- → NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease(2018)9,922 cited
- → Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease(2011)7,021 cited
- → Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects(2009)2,070 cited
- → Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup(2024)1,822 cited
- → Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease(2014)1,626 cited
- → A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease(2013)1,197 cited